FDA approval of GLP-1 receptor agonist (liraglutide) for use in children

Lancet Child Adolesc Health. 2019 Sep;3(9):595-597. doi: 10.1016/S2352-4642(19)30236-6. Epub 2019 Jul 22.
No abstract available

MeSH terms

  • Adolescent
  • Child
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Approval*
  • Glucagon-Like Peptide-1 Receptor / agonists*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Liraglutide / therapeutic use*
  • United States
  • United States Food and Drug Administration
  • Young Adult

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Liraglutide